Pricing Log in Create free account

AEON Biopharma, Inc. (AEON) vs Psyence Biomedical Ltd. (PBM)

AEON Biopharma, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Psyence Biomedical Ltd. is the larger, with a market value of $11.2M against $9.4M — 1.2× the size. AEON Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Across the 7 metrics below, AEON Biopharma, Inc. leads on 4 and Psyence Biomedical Ltd. on 3.

Valuation

Metric AEON PBM Biotechnology median
P/E n/m 0.13 10.26
P/S n/m n/m 9.18
P/B n/m 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 1.91 0.65
EV/Sales n/m n/m 8.98
Earnings yield (2,762.50%) 759.84% (34.89%)
Free cash flow yield (168.78%) (1,147.64%) (24.52%)

Profitability

Metric AEON PBM Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 350.00% (23.52%) (50.12%)
Return on assets (621.70%) (6.74%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON PBM Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (105.42%) (138.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.54 8.09 4.89
Net debt to EBITDA (2.48) 1.20 1.01

Dividend

Metric AEON PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AEON PBM Biotechnology median
Market cap 9.35m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack